(Date:5/12/2008)...neurological recovery in severely-injured, acute ...with Cethrin, HOPKINTON, Mass., May 12 /PRNewswir...daq: ALSE ) today announced 12-month interim data... proprietary recombinant,protein that is being inv...ensory function after spinal cord injury, or SCI. ...
(Date:5/12/2008).../PRNewswire-USNewswire/ -- GlaxoSmithKline (GSK),...up (BIG), a leading,academic breast cancer researc...sh Breast Cancer Cooperative Group (SOLTI), today ...at will examine the role of TYKERB(R) in the,treat...t Lapatinib and/or,Trastuzumab Treatment Optimizat...
(Date:5/9/2008)...RNewswire-USNewswire/ -- Many strong acting pain,m... include nausea and,vomiting with short-term use, ...mptoms can lead patients to discontinue treatment,...t for physicians. The novel investigational,medica..., provided pain,relief for patients with fewer gas...
(Date:5/9/2008)...hase III Study Shows Positive Results with X-ray ...J., May 9 /- Roche today announced on... showing that ACTEMRA(TM),(tocilizumab) can signif...o,joints in patients with rheumatoid arthritis (RA...eatment. The study also demonstrated that ACTEMRA,...
Breaking Medicine Technology:Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 2Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 3Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 4Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 2New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 3New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5Walnuts Rank High on New Nutrition Scales 12319 1Walnuts Rank High on New Nutrition Scales 12319 2Walnuts Rank High on New Nutrition Scales 12319 3Groundbreaking Deloitte Survey Reveals Many U S Consumers Want Major Changes in Health Care Design Delivery 12317 1Groundbreaking Deloitte Survey Reveals Many U S Consumers Want Major Changes in Health Care Design Delivery 12317 2Groundbreaking Deloitte Survey Reveals Many U S Consumers Want Major Changes in Health Care Design Delivery 12317 3Groundbreaking Deloitte Survey Reveals Many U S Consumers Want Major Changes in Health Care Design Delivery 12317 4Achilles Tendon Surgery Advances Speed Recovery 12315 1Achilles Tendon Surgery Advances Speed Recovery 12315 2Varian Medical Systems Announces Symposia on RapidArc Technology for Faster More Precise Radiotherapy Treatments 12313 1Varian Medical Systems Announces Symposia on RapidArc Technology for Faster More Precise Radiotherapy Treatments 12313 2Varian Medical Systems Announces Symposia on RapidArc Technology for Faster More Precise Radiotherapy Treatments 12313 3...Against Rheumatism,(EULAR) Congress Demonstrates t...h Rheumatoid Arthritis, LONDON, England; PHILADELP..., 2007 /PRNewswire-FirstCall/ -- GlaxoSmithKline,(...itive primary,efficacy data (evaluated at 24 Weeks...an Congress of Rheumatology (abstract,number: OPO2...
...amoxifen in,a Single Trial , LUTON, UK, Friday 15... single trial has demonstrated that survival in,ea... switching from,tamoxifen to anastrozole (Arimidex...NO 95) study, published online in The,Journal of C...en,who have been taking tamoxifen as part of their...
Other Medicine Technology:GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 2GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 3GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 4GlaxoSmithKline and Genmab Present Positive Phase II Results With,ofatumumab in Patients With Rheumatoid Arthritis (RA) 5Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 2Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 3Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 4Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal,Women with Early Breast Cancer Receiving Treatment with Tamoxifen 5(Date:5/13/2008)...treat the poor from improving, study finds , ...lity of care at hospitals that treat poor and unde...s, is lagging well behind hospitals that do not se...hospitals, which rely on state and federal funding...money to improve the quality of care at the same r...
(Date:5/13/2008)...but well-known genetic disorder may hold wider pro... potentially lethal enlarged hearts, due mainly to...hows. , The common denominator in both phenylk...ical tetrahydrobiopterin (BH4). In PKU, this enzy...anine whose buildup is toxic to the brain. In the...
(Date:5/13/2008)...RNewswire/ -- CJPS Enterprises, LLC, (http://www.C... be holding a,half-day mini-seminar and interactiv...intellectual property for companies to increase th...is seminar will take place in,Detroit,s TechTown o...large,and small companies., This session, which i...
(Date:5/13/2008)...ealthy gene into brain slowed Batten disease , ... gene therapy that involves injecting a harmless v...fective way to slow Batten disease, a rare neurolo...the ages of 8 and 12. , Children with the disea...ipofuscinosis, are born with a mutated CLN2 gene. ...
Breaking Medicine News(10 mins):Health News:Quality Lags at Safety-Net Hospitals 2Health News:Quality Lags at Safety-Net Hospitals 3Health News:Drug therapy for PKU reverses heart damage 2Health News:Drug therapy for PKU reverses heart damage 3Health News:Drug therapy for PKU reverses heart damage 4Health News:Intellectual Property Buildup Seminar to be Held in Detroit 2Health News:Therapy Yields Promise for Fatal Neurological Condition 2...ers now say people who are considered obese are si...beat // according to a recent study . They say th...artbeats can lead to earlier death, even when peop...nging the heartbeat back to normal. Researchers sa...
...hritis of the knee is very common, affecting almos...thritis is an incurable illness //, so treatment i...ich is why acupuncture was studied. Acupuncture in...the knee is more effective than drug treatment alo...
...atients treated with ultrasound therapy in additio... // compared to patients only treated with medicat...d 126 patients who suffered acute ischemic stroke ... artery. All the patients were treated with tissue...
...arch shows inhaled insulin is effective and well t...treatment also provides glycemic control comparabl..., 335 participants randomly received either inhale... to three injections of regular insulin for six mo...
Other Medicine News:...ortex® Thermovent® T helps provide protect...ent. It is small and extremely lightweight making ...ts. With a high rate of heat and moisture recovery... retention., ,All HMEs and filters have ISO stand...
Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
...lti-Mist™ HME product line has the right pro...ults and from intubated patients to patients with ...ification for both anesthesia and critical care ap...rovide maximum protection for patients and staff m...
Medicine Products: